Michael Briganti

Strategic, board-facing internal audit, risk, and compliance executive with 25+ years of global leadership experience across biopharma, life sciences, medical device, and consumer products organizations. Proven history building and transforming Internal Audit, SOX, risk management, and compliance programs while partnering with Boards, Audit Committees, C-Suite executives and business leaders. Experienced in establishing risk-based, strategic audit functions, strengthening control environments, leading through significant organizational and business transformation, and applying data analytics and emerging technologies to improve assurance and business performance.

Recognized for a collaborative, business-oriented approach that positions Internal Audit as a strategic partner while maintaining independence and objectivity.

Senior Director, Internal Audit; Director, Internal Audit at GENMAB (2021-06 – Present)

Built and led Genmab’s first Internal Audit function from the ground up, during a period of significant organizational growth, global expansion, and commercial product launches. Responsible for day-to-day oversight of the function, while establishing its strategy, governance, operating model, talent structure, and risk-based approach.

• Established risk-based audit and advisory coverage across $2B+ of global operations, including commercial operations, SAP ERP implementation, third-party CRO governance, supply chain, artificial intelligence, healthcare compliance, information technology, and cybersecurity.
• Identified $10M+ in savings and recovery opportunities through risk-based supply chain audits and advisory reviews, demonstrating tangible business value from Internal Audit.
• Matured the Company’s SOX compliance program in less than three years through risk assessment, automation, a strategic shift toward limited third-party assistance for SOX testing, and strong external auditor coordination, achieving single-digit deficiencies by year 3.
• Developed data analytics, continuous-monitoring, and AI capabilities, automating audit administration, SOX deficiency tracking, quarterly SOX 302 certifications, and fraud-risk assessments; ongoing expenditures monitoring generated $1M+ in annual savings.
• Led special projects including confidential investigations, acquisition due diligence, application pre-implementation reviews, cross-functional AI/data-analytics initiatives, and Finance’s approach to safely implementing AI consistent with SDLC policies and principles.
• Built a seven-person Internal Audit organization through coaching, mentoring, succession planning, and a guest-auditor program.
• Strategically leveraged co-source resources to supplement internal audit capabilities and provide specialized expertise in cybersecurity and IT audit engagements, achieving broader technology risk coverage.
• Partnered with executive leadership on annual Internal Audit planning and enterprise risk assessment, contributing to the Company’s ERM program; provide quarterly Audit Committee reporting on Internal Audit, SOX, compliance, and fraud risks.
• Achieved Institute of Internal Audit professional practice compliance following quality assurance review.

Director, International Risk Management at BRISTOL-MYERS SQUIBB (2016-03 – 2021-06)

Led international risk management within Finance’s Business Controls and Risk Management organization, reporting to the Corporate Controller, with responsibility for a distributed team of international compliance and risk-management professionals supporting global commercial operations.

• Led a global organization of 50+ compliance, controls and risk-management professionals across North America, Europe, Asia, Central & South America, and the Middle East, supporting commercial operations, with responsibility for SOX controls, compliance and anti-fraud monitoring, risk assessment, investigations, and third-party risk management.
• Designed and executed third-party risk-management audits covering distributors, contract sales organizations, and third-party logistics providers, generating $7M+ in recovery opportunities.
• Developed and oversaw healthcare-professional interaction and global-expenditure monitoring analytics, strengthening compliance oversight and executive reporting, cited as one of the company’s top 5 digital innovations in the year of implementation.
• Reported regularly to the Audit Committee and senior Commercial and Finance leadership, integrating control deficiencies, SOX compliance, remediation status, control changes, and emerging monitoring trends to establish priorities and drive accountability.

Senior Manager, Assurance & Integrity Services at ERNST & YOUNG (2014-03 – 2016-03)

• Led proactive internal-control reviews for life-sciences organizations, assessing compliance with industry regulations, regulatory expectations, and leading practices, and identifying and remediating control gaps.
• Led complex accounting and Foreign Corrupt Practices Act investigations, including root-cause analysis, remediation, and control enhancements.
• Advised clients on internal-control design and implementation in support of OIG guidance and Corporate Integrity Agreements through risk/control assessments and outsourced Internal Audit engagements.
• Managed compliance-monitoring programs, including live speaker-program monitoring, with reporting and analysis provided to client Legal teams.

Manager, Internal Audit at CONAIR CORPORATION (2008-02 – 2014-03)

Directed global operational audits and SOX compliance for a $2B consumer-products company, overseeing five auditors across the United States, Europe, and Asia. Led global operational and financial audits, risk assessments, and SOX compliance activities; developed audit plans, reports, and Audit Committee communications.

Senior Manager, Assurance Services at CIPOLLA SZIKLAY, LLC (2007-04 – 2008-02)

Managed external assurance, outsourced Internal Audit, forensic and SOX compliance engagements across multiple industries.

Manager, Internal Audit at DATASCOPE CORPORATION (2003-02 – 2007-04)

Planned and executed SOX compliance, operational audits, and investigations for a $350M medical-device manufacturer while supervising three Internal Audit professionals. Led initial SOX compliance implementation, delivering the program for $130K against a $500K budget; audits across procurement, IT, fixed assets, travel and expense, and other functions identified cost-saving opportunities exceeding $1M.

Senior Auditor, Assurance & Advisory Services at DELOITTE (2000-08 – 2003-02)

Planned and supervised public-company financial statement audits for pharmaceutical and medical-device clients under GAAP and IFRS.

Juris Doctor, Cum Laude – SETON HALL UNIVERSITY SCHOOL OF LAW (2008)

M.S. / B.S., Magna Cum Laude in Accounting – FAIRLEIGH DICKINSON UNIVERSITY (2000)